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After publication of the original article [1], Additional 
file 1 was updated with the following statement, located 
towards the end of the document:
“Reproduced with permission from: Mannino DM, Higu-
chi K, Yu T-C, Zhou H, Li Y, Tian H, et  al. Economic 
burden of chronic obstructive pulmonary disease by 
presence of comorbidities. CHEST Journal. Published 
online February 12, 2015. doi:10.1378/chest.14-2434.”
This is to credit an earlier publication in which the 
same additional file was used. The updated additional file 
(Additional file 1) can be found below.
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